Background: Patients with gastrointestinal and hepatobiliary disorders
, either congenital or acquired early in childhood, are at high risk f
or various endocrine and metabolic abnormalities. Case report: A 27-ye
ar-old woman with Alagille's syndrome presented with progressive jaund
ice and gait disturbances following surgery and ingestion of oral cont
raceptives. On physical examination, short stature, facial dysmorphism
and neuromuscular symptoms such as polyneuropathy and spinocerebellar
ataxia were noted. Serum concentrations of total bilirubin (54 mg/dl)
and alkaline phosphatase were markedly increased, whereas serum level
s of haptoglobin, zinc, vitamin D and E were decreased. Although prehe
patic or intrahepatic etiologies of jaundice were more likely in this
patient, posthepatic etiologies were ruled out by abdominal ultrasound
and endoscopic retrograde cholangio-pancreaticography. Based on a wor
king diagnosis of acute drug-induced cholestasis, treatment with high
doses of lipid-soluble vitamins and ursodeoxycholic acid was initiated
. In response to therapy, her abnormal laboratory results normalized a
nd her neurologic symptoms markedly improved. Conclusion: This clinico
pathological conference of a patient with Alagille's syndrome illustra
tes the clinical presentation and therapy of metabolic and endocrine c
omplications in chronic cholestasis.